Insmed
INSM
#1069
Rank
โ‚น2.119 T
Marketcap
โ‚น9,706
Share price
-1.24%
Change (1 day)
-32.50%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น71.39 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น1.13 Billion. In 2025 the company made an earning of -โ‚น115.36 Billion a decrease over its 2024 earnings that were of -โ‚น80.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น71.39 Billion-38.12%
2025 -โ‚น115.36 Billion43.91%
2024 -โ‚น80.16 Billion23.71%
2023 -โ‚น64.8 Billion45.77%
2022 -โ‚น44.46 Billion15.83%
2021 -โ‚น38.38 Billion50.19%
2020 -โ‚น25.56 Billion16.4%
2019 -โ‚น21.96 Billion-23.9%
2018 -โ‚น28.85 Billion59.35%
2017 -โ‚น18.11 Billion8.52%
2016 -โ‚น16.69 Billion47.25%
2015 -โ‚น11.33 Billion34.53%
2014 -โ‚น8.43 Billion58.83%
2013 -โ‚น5.31 Billion35.14%
2012 -โ‚น3.93 Billion-31.92%
2011 -โ‚น5.77 Billion854.92%
2010 -โ‚น0.61 Billion-105.22%
2009 โ‚น11.55 B-905.06%
2008 -โ‚น1.44 Billion-27.31%
2007 -โ‚น1.98 Billion-62.41%
2006 -โ‚น5.26 Billion98.19%
2005 -โ‚น2.66 Billion0.03%
2004 -โ‚น2.65 Billion159.07%
2003 -โ‚น1.03 Billion-69.31%
2002 -โ‚น3.34 Billion
2000 -โ‚น3.01 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.499 T-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚น188.86 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น487.24 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.65 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.25 Billion-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น4.99 Billion-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA